Immunologic Marker
Showing 1 - 25 of 3,764
Autoimmune Diseases, Lupus Erythematosus, Systemic, Communicable Diseases Trial in Atlanta
Enrolling by invitation
- Autoimmune Diseases
- +2 more
-
Atlanta, Georgia
- +2 more
May 17, 2022
Early Onset Preeclampsia and Nectin-4
Completed
- Pre-Eclampsia
- +3 more
- serum marker levels
-
İstanbul, TurkeyHatice Akkaya
Oct 16, 2021
Sepsis in Immunodeficiency ICU Patients
Completed
- Sepsis
- Immune Deficiency
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Apr 28, 2021
HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)
Completed
- HIV Infections
- MN rgp120/HIV-1 and A244 rgp120/HIV-1
- +2 more
-
Baltimore, Maryland
- +3 more
Oct 28, 2021
Immunologic Signatures Following Surgery for Pancreatic Cancer
Active, not recruiting
- Pancreatic Cancer
- Surgery
-
Durham, North CarolinaDuke University Health System
Jun 24, 2022
Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Not yet recruiting
- Breast Carcinoma
- Invasive Breast Carcinoma
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 28, 2022
Perioperative Early Tiredness in Epithelial Ovarian Cancer
Completed
- Perioperative Early Tiredness (Acute Fatigue)
- +4 more
-
Berlin, GermanyDepartment of Anesthesiology and Intensive Care Medicine, Campus
Aug 30, 2022
Acute Myocardial Infarction Trial in Örebro (Examination and analysis of sweat and blood samples at baseline and at follow up,
Completed
- Acute Myocardial Infarction
- Examination and analysis of sweat and blood samples at baseline and at follow up
- Examination and analysis of sweat and blood samples at baseline
-
Örebro, SwedenDepartment of cardiology
Apr 24, 2023
Acute Pancreatitis, Exocrine Pancreatic Insufficiency, Gut Microbiota Trial in Coimbra (Pancreatic Enzyme Replacement Therapy,
Recruiting
- Acute Pancreatitis
- +3 more
- Pancreatic Enzyme Replacement Therapy
- Placebo
-
Coimbra, PortugalCentro Hospitalar e Universitário de Coimbra, E.P.E.
Jul 27, 2022
Kidney Failure, Chronic Trial in Seoul (Monofer (experimental), control group)
Not yet recruiting
- Kidney Failure, Chronic
- Monofer (experimental)
- control group
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 5, 2023
Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)
Terminated
- Metastatic Melanoma
- Tumor Infiltrating Lymphocytes
- Nivolumab and Ipilimumab
-
New Haven, ConnecticutYale New Haven Hospital
Jul 20, 2022
Biomarkers of Chronic Obstructive Pulmonary Disease
Recruiting
- COPD
- +2 more
- Physical examinations
- blood test
-
Amiens, FranceCHU Amiens
Jul 5, 2021
Serum IL 26 as a Marker of Disease Activity in SLE
Not yet recruiting
- SLE
- (no location specified)
Dec 16, 2021
Immune Biomarker Study for Head and Neck Cancer
Recruiting
- Head and Neck Cancer
- +4 more
- Sampling
-
Erlangen, Bavaria, Germany
- +2 more
Jan 23, 2023
Chronic Fatigue Syndrome Trial in Stanford (valganciclovir)
Completed
- Chronic Fatigue Syndrome
-
Stanford, CaliforniaStanford University Medical Center
May 23, 2022
Infant Formula Trial in Malmö, Umeå (Partially hydrolysed formula)
Recruiting
- Infant Formula
- Partially hydrolysed formula
-
Malmö, Sweden
- +1 more
Oct 10, 2022
Unrecognized Condition Trial in Kaohsiung (Intravascular laser irradiation of blood)
Recruiting
- Unrecognized Condition
- Intravascular laser irradiation of blood
-
Kaohsiung, TaiwanDepartment of Obstetrics and Gynecology, Kaohsiung Veterans Gene
May 24, 2023
Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)
Active, not recruiting
- Recurrent Melanoma
- selinexor
- Correlative studies
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022
Immunologic Checkpoint Inhibitors in NSCLC
Not yet recruiting
- Non Small Cell Lung Cancer
- Immune checkpoint inhibitor
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 23, 2021
Metabolic Syndrome, Diabetes Trial in Amsterdam (6-BT, Placebo)
Recruiting
- Metabolic Syndrome
- Diabetes Mellitus
- 6-BT
- Placebo
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Jul 25, 2023
Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)
Not yet recruiting
- Renal Cell Carcinoma
- Pembrolizumab infusion
- Lenvatinib tablet
-
Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
Feb 8, 2023
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Altered Transcriptomic and Immune Accompanied by Identification
Recruiting
- Breast Cancer Patients
- surgery for breast cancer and imaging test evaluations
-
Naples, ItalyIRCCS Synlab SDN
Mar 29, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023